dc.date.accessioned2019-08-08T15:23:46Z
dc.date.available2019-08-08T15:23:46Z
dc.date.created2019-08-08T15:23:46Z
dc.date.issued2019
dc.identifierhttps://hdl.handle.net/20.500.12866/7148
dc.identifierhttps://doi.org/10.1016/S1473-3099(19)30387-1
dc.description.abstractWHO estimates that 1·6 million people die each year before or during tuberculosis treatment. In The Lancet Infectious Diseases, Kamila Romanowski and colleagues' meta-analysis showed that tuberculosis survivors have approximately three-times to four-times greater mortality than their local populations, including among younger adults. These transformative findings show that tuberculosis, already the most frequent cause of death from a single infectious agent, is associated with even greater mortality than current estimates. This excessive tuberculosis-associated mortality and the proposed pathways that might explain it are summarised in the figure...
dc.languageeng
dc.publisherElsevier
dc.relationLancet. Infectious Diseases
dc.relation1474-4457
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectcardiovascular effect
dc.subjectcause of death
dc.subjectcomorbidity
dc.subjectglobal disease burden
dc.subjecthuman
dc.subjectHuman immunodeficiency virus infection
dc.subjectincidence
dc.subjectischemic heart disease
dc.subjectmalignant neoplasm
dc.subjectmeta analysis (topic)
dc.subjectmortality rate
dc.subjectNote
dc.subjectpoverty
dc.subjectpriority journal
dc.subjectpulmonary hypertension
dc.subjectrecurrent disease
dc.subjectreinfection
dc.subjectrespiratory failure
dc.subjectsmoking
dc.subjectsocial determinants of health
dc.subjectsurvival
dc.subjecttuberculosis
dc.titleHealthy survival after tuberculosis.
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución